Alicia Secor
CIK: 0001584516
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (4 total)
- Jun 4, 2026ZVRA
ZEVRA THERAPEUTICS, INC.
Award(A)DirectStock Option (right to buy)
30K shares- - Dec 2, 2025ZVRA
ZEVRA THERAPEUTICS, INC.
Award(A)DirectStock Option (right to buy)
45K shares- - Sep 18, 2024GTHX
G1 Therapeutics, Inc.
Disposition(D)Direct20K shares- - Sep 18, 2024GTHX
G1 Therapeutics, Inc.
Tender Offer(U)Direct10K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 4, 2026 |  ZVRA ZEVRA THERAPEUTICS, INC. | Award(A) Stock Option (right to buy) | 30,000 | - | - | Direct |
| Dec 2, 2025 | ZVRA ZEVRA THERAPEUTICS, INC. | Award(A) Stock Option (right to buy) | 45,000 | - | - | Direct |
| Sep 18, 2024 |  GTHX G1 Therapeutics, Inc. | Disposition(D) | 20,000 | - | $0 | Direct |
| Sep 18, 2024 | GTHX G1 Therapeutics, Inc. | Tender Offer(U) | 10,000 | - | $0 | Direct |
1-4 of 4 transactions
About Secor Alicia
Secor Alicia (SEC CIK 0001584516) files insider reports with the SEC as Director of ZEVRA THERAPEUTICS, INC. (ZVRA) and Director of G1 Therapeutics, Inc. (GTHX).
Signal8 holds 4 ownership filings by Secor Alicia (1 Form 3, 3 Form 4), filed between Sep 18, 2024 and Jun 18, 2026. Those filings report 4 transactions, from Sep 18, 2024 to Jun 4, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Secor Alicia's filings is in BOSTON, MA.
Recent filings by Secor Alicia
- Jun 4, 2026: Grant or award of ZVRA derivative securities (Form 4, code A).
- Dec 2, 2025: Grant or award of ZVRA derivative securities (Form 4, code A).
- Sep 18, 2024: Disposition to issuer transaction of GTHX shares (Form 4, code D).
- Sep 18, 2024: Tender of shares transaction of GTHX shares (Form 4, code U).
Other insiders filing for ZEVRA THERAPEUTICS, INC. (ZVRA)
- McFarlane Neil F., President and CEO
- Thompson Rahsaan, Chief Legal & Compliance
- Watton Corey Michael, Director
- FAVORITO TAMARA A, Director
- Calder Douglas W, Director
- Anderson Thomas, Director